CENTURY THERAPEUTICS INC's ticker is IPSC and the CUSIP is 15673T100. A total of 65 filers reported holding CENTURY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $180,555 | +10.0% | 70,806 | +80.2% | 0.00% | – |
| Q1 2024 | $164,203 | +10.8% | 39,283 | -12.0% | 0.00% | – |
| Q4 2023 | $148,155 | +53.4% | 44,625 | -7.6% | 0.00% | – |
| Q3 2023 | $96,556 | -29.3% | 48,278 | +11.7% | 0.00% | – |
| Q2 2023 | $136,547 | -25.7% | 43,211 | -18.4% | 0.00% | – |
| Q1 2023 | $183,799 | +18.8% | 52,968 | +75.7% | 0.00% | – |
| Q4 2022 | $154,670 | +74260.6% | 30,150 | +43.2% | 0.00% | – |
| Q3 2022 | $208 | -3.7% | 21,056 | -18.3% | 0.00% | – |
| Q2 2022 | $216 | -99.9% | 25,768 | +24.2% | 0.00% | – |
| Q1 2022 | $261,000 | -11.8% | 20,746 | +11.2% | 0.00% | – |
| Q4 2021 | $296,000 | -80.9% | 18,655 | -64.7% | 0.00% | – |
| Q2 2021 | $1,549,000 | – | 52,808 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 702,623 | $11,144,000 | 2.17% |
| Casdin Capital, LLC | 3,206,380 | $50,853,000 | 1.43% |
| Logos Global Management LP | 614,095 | $9,739,000 | 1.00% |
| Parametrica Management Ltd | 28,855 | $459,000 | 0.46% |
| DAFNA Capital Management LLC | 100,135 | $1,588,000 | 0.40% |
| Avidity Partners Management LP | 851,522 | $13,505,000 | 0.29% |
| Deep Track Capital, LP | 250,000 | $3,965,000 | 0.28% |
| RA Capital Management | 914,094 | $14,498,000 | 0.26% |
| HHLR ADVISORS, LTD. | 614,095 | $9,740,000 | 0.15% |
| Orbimed Advisors | 307,047 | $4,870,000 | 0.06% |